PharmiWeb.com - Global Pharma News & Resources

Events

The 2022 EAHP Annual Congress will bring about a vast of novel scientific and practical knowledge upon which we can further develop and strengthen our services for our patients in Europe and beyond. Therapeutic possibilities are growing rapidly in several disease groups, including those for which treatment options have been seriously limited for many decades. These emerging therapeutic modalities have brought about many challenges for hospital pharmacists and they keep changing the way pharmacy services are delivered. Hospital pharmacists have to acquire more knowledge related to immunology, infection control, the human genome, cell regulation and much more. Besides these novel therapeutic areas, our emerging competencies of frontline patient care in the clinical setting call for new and c…
With the amalgamation of speakers from Diabetes Conference 2020 is privileged to announce its “Diabetes Meet 2022” which will be held from March 21-22, 2022 at Berlin, Germany. We cordially welcome all the eminent researchers, students, and delegates to take part in this upcoming Diabetes Conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Obesity, Endocrinology & Diabetes. The upcoming Diabetes Meet 2022 will be focusing upon the theme Advances in the evaluation and treatment of Diabetes to help improve communication and knowledge among professionals, community and to provide a platform for international colleagues, delegates to establish corporations and stimulating presentations. https://rebrand.ly/21g22b The conference wi…
2nd Edition of International Conference on Diabetes and Obesity
09-Feb-2022 - 10-Feb-2022
SMi Group’s 13th Annual Conference: RNA Therapeutics 2022 9th – 10th February 2022 London, UK www.therapeutics-rna.com/pharmiweb     Sponsored by: BIA Separations & eTheRNA Immunotherapies Bolstering the latest advances and opportunities in RNA-based medicine   The RNA therapeutics industry has grown at an exponential rate in recent years, with an increased spotlight following the industry’s leading role in developing vaccines against COVID-19 in response to the global pandemic. This year’s conference will reflect on how the industry has adapted and played a pivotal role in global health over the past year and will discuss the takeaways for future mRNA therapeutic development.   The 2022 agenda will explore innovations in novel and targeted delivery, RNAi innov…
RNA Therapeutics 2022
Taking place this January in Boston, the HFpEF Drug Discovery & Development Summit 2022 is the first and only devoted meeting uniting large pharma, biotech, and pioneering academics under the mutual and ambitious objective of accelerating the practical discovery, translation, and clinical development of safe, effective and deliverable therapies to treat HFpEF, an extremely common heart failure with a huge unmet medical need. Join 80+ experts at this ground-breaking forum with the likes of AstraZeneca, Eli Lilly, Bayer, Amgen, Novartis, and many more sharing state-of-the-art insights and expertise in heart failure. Covering topics including specific and applied drug development hurdles with inadequate successful treatments, such as the translational challenges between phases of pre-clin…
HFpEF Drug Discovery & Development Summit 2022
With the recent clinical validation by BMS, LAG-3 combinations are spearheading the next wave of immune checkpoint inhibitors. As such, there has been an explosion of interest and high-scale investment into this exciting space. Arriving at a critical point for LAG-3 development, the first ever LAG-3 Targeted Drug Development Summit is the definitive industry-led event focused on propelling this next generation inhibitor to clinical use. Ensure your LAG-3 program reaches full clinical potential through hearing from experts discuss: The progress that has been made and challenges faced in bispecific antibody based approaches Improving combination therapy regimens Better understanding the underpinning biology of LAG-3 as a cancer target Utilizing biomarkers to understand the interplay between…
LAG-3 Targeted Drug Development Summit 2022
Cell therapies hold life-saving potential for patients and the race is on to develop best-in-class, living, 'thinking' drugs. Relapse rates and barriers to solid tumor efficacy mean the cell therapy industry must innovate, now more than ever. Due to its successful first edition, the Multi-Functional Cell Therapies Summit is returning for 2022 and will be uniting global leaders to discuss strategies to weaponize cell therapies with antigenic, engineered, and combination approaches to create sophisticated multi-functional systems. View the full event brochure here: https://ter.li/6o9ghc The 2nd Annual Multi-Functional Cell Therapies Summit remains the only cell-type agnostic, targeting focused meeting providing a platform for overcoming the challenges to weaponizing cell therapies against so…
2nd Annual Multi-Functional Cell Therapies Summit
Together we will increase the length and quality of patient survival from diagnosis. The 3rd Glioblastoma Drug Development Summit is the only industry led forum for large pharma, biotech and academic KOLs to unite under the common goal of accelerating the practical translation and clinical development of meaningful therapies for the treatment of glioblastoma. Through investigating the clinical implementation of diverse mechanisms of action, including, DNA damage repair, immunotherapy, oncolytic viruses, cholesterol metabolism, PARP inhibitors and more, we strive to address the urgent need for novel and much improved treatments for this devastating disease. Tackling specific drug development challenges such as a better understanding of preclinical efficacy and tolerability data to confident…
3rd Glioblastoma Drug Development Summit
SMi's flagship microbiology conference is celebrating its 10 year anniversary. The conference taking place on 17 and 18 January 2021 in London, UK will bring together microbiology industry experts. Microbiology remains an essential tool for the detection of microorganisms present in biopharmaceutical and pharmaceutical batches. The two-day conference will explore the most pressing topics in this thriving field, from the movement toward process automation and minimisation of operator intervention, to the latest technologies in rapid microbiological testing methods and data integrity. Event Hashtag: #SMiPharmaMicro Key Reasons to Attend:- Discover case studies in establishing holistic Contamination Control Strategies and Real-Time Viable Air Particle Counting with leaders in the pharmaceutic…
SMi's 10th Annual Pharmaceutical Microbiology UK Conference
The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products. This year’s conference will explore the exciting advances in the combination product delivery space including insights into how the industry is adapting to the delayed EU MDR, takeaways from the global pandemic and a future outlook exploring how pharma, device developers and regulators can work together to encourage innovation. Part of the leading injectables series of events, SMi’s 14th annual conference will bring you the key insights you need to grow and enhance your pre-filled syringes portfolio and discover what the future holds for the PFS and combination prod…
Pre-Filled Syringes and Injectable Drug Devices Conference
Greetings from the Pathology Utilitarian Conference. On the behalf of Utilitarian Committee, we warmly welcome you to the 10th Emirates Pathology & Digital Pathology Utilitarian Conference (10EPUCG2022). The motto of the Pathology Conference –10EPUCG2022:Where pathologists meet innovation & technology for a better outcome. We have an exciting and informative program at the Pathology Congress that will allow the participants to reflect upon and celebrate our accomplishments, renew collaboration and extend their networking, and to investigate current and future research in a particular direction. Pathology Conference Program will encourage discussions and hope to inspire members from a wide array of themes to initiate networking and collaboration within and across disciplines for the…
 10th Emirates Pathology & Digital Pathology Utilitarian Conference
16-Dec-2021 - 18-Dec-2021

CPhI & P-MEC China drives growth and innovation at every step of the Chinese and global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI & P-MEC China brings together pharmaceutical professionals of the whole pharma industry to network, identify business opportunities and expand the global market. Co-locating with ICSE for contract services; P-MEC for machinery, equipment & technology; InnoPack for pharmaceutical packaging; bioLIVE for biopharma; Finished Dosage Formulation for every aspect of the finished dosage supply chain; LABWorld for laboratory equipment and instrument; NEX for natural extract products, applications and solutions; and other vertical zones including Excipients, Animal, MSE, EP…

Learn the different payer archetype systems that offer useful patterns in payer decision making and an insightful structure in Europe’s highly fragmented payer landscape – Grasp the structure and know the key stakeholders of the major European healthcare systems – Understand the contribution of other functions in the process of gaining optimal access Why You Should Attend The Content: Throughout the industry, optimising market access is often viewed as a responsibility of the market access departments alone, while in fact the optimal outcome will depend on a cross-functional effort as of phase II. That is why it is absolutely necessary that internal stakeholders in non-market access functions grasp the fundamentals and understand how their function, and in particular their decisions r…
Online Course: Understanding Pharma Market Access & Payers in Europe by Dr. Nick Proctor
Returning for the 3rd year, the Cell Therapy Analytical Development Summit is the leading industry-defining forum made exclusively for analytical, CMC, QC, and process development experts. New for 2021, take advantage of two tracks of content showcasing:• Automated analytical processes to reduce turnaround time• Strategies to validate novel assays for next generation therapies• New genomic testing technology to gain a deeper understanding of the cell product• Experience in navigating regulatory guidelines to reduce delays… To equip your team with the lessons learned to achieve success in analytical submission from IND through to commercialization. Learn from analytical trailblazers at bluebird bio, BMS, Kite, Novartis and more to support your efforts in developing safe and effective cell t…
Cell Therapy Analytical Development Summit
The 3rd Targeted Radiopharmaceuticals (TRP) Summit returns at a crucial time for the entire industry. Spurred on by positive Phase III VISION trial data, there has been huge research investment, on both sides of the Atlantic, on how to deliver radiation therapy directly and specifically to tumours. For the 2021 edition of this conference, there will be the opportunity to attend either in-person in Berlin or remotely via a dedicated digital networking platform with all the access to the conference content. You can expect a wider array of insights from recent case studies to help you accelerate the development of the next generation of radioligand therapies from clinical approval to commercialisation. As the only industry-led platform for discussing challenges and opportunities facing develo…
3rd Targeted Radiopharmaceuticals (TRP) Summit

Online, United States

The 4th Commercializing Clinically Validated Digital Therapeutics Summit returns in December of 2021 as the only industry-led meeting deep-diving on stakeholder alliance and partnership to accelerate DTx scalability, to enable building sustainable & viable business models. Across 3 days covering extensive and valuable content, we will bring together expert speakers to share their data on case studies of lessons learnt and keys to success, as well as insights into venturing into effective partnerships. This will give you the tools to conquer your most crucial challenges and accelerate sustainable scalability and adoption of your digital therapeutic. Whether you are a drug, med device or a DTx developer, this is your must-attend event in 2021. Hear from your peers’ journeys and lessons l…
4th Commercializing Clinically Validated DTx
06-Dec-2021 - 08-Dec-2021
The inaugural ADC Target Selection Summit developed in collaboration with AstraZeneca, AbbVie, Mersana and Eisai is the industry’s definitive conference dedicated to exploring the importance of ADC target selection, discussing the validation of novel targets, understanding the patient population for a certain target and therefore developing life-changing ADCs. Join your peers within target discovery from large pharma, innovative biotech and research institutes to discuss key challenges including the target-payload pairing and ensuring that it’s right from the get-go, differentiating solid tumors and hematological cancer targets and assessing the antibody for small molecule target validation. As part of the World ADC Series this virtual meeting is the go-to for scientists involved within ta…
ADC Target Selection Summit
2nd Euro Diabetic and Endocrinology Congress is a unique forum for Diabetologists and Endocrinologists with comparable levels of experience & education to present, exchange ideas, and develop collaborative networks in both academia and industry. It further provides opportunities for Physicians and Young Researchers to meet, discuss ideas from a small group of eminent, field-leading scientists in an informal and friendly atmosphere.   Target Audience: Diabetologists Endocrinologists Cardiologists Bariatric Surgeons Nutritionists and Dietitian Podiatrists Physical Therapists Epidemiologists Clinical Researchers Conference Central Topics: Clinical Diabetes and Advanced Technologies Diabetes and Nutrition Pediatric Diabetes and Endocrinology Obesity, Metabolic Syndrome and Dia…
2nd Euro Diabetes and Endocrinology Congress

6201 America Center Drive, Suite 240, San Jose, CA, 95002, United States

The Process Validation Guidelines (January 2011) and the EU Annex 15: Qualification and Validation (October 2015) outline the general principles and approaches the two regulatory bodies consider appropriate elements of process validation for the manufacture of human and animal drugs and biological products, including Active Pharmaceutical Ingredients (APIs). These guidances align Process Validation activities with a product lifecycle concept and with existing FDA and EU guidances, including the FDA/International Conference on Harmonization (ICH), Guidance for Industry, Q8 (R2) Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System. The lifecycle concept, new to these Guidances, link product and process development, qualification of the commercial manu…